TRENDING :  Market Movers  |  Top 50   SPY (0.23%)    TSLA (-2.49%)    CANF (1.36%)    BYND (-2.96%)    BTCUSD (%)    AMZN (0.43%)    DIS (0.05%)    ONCS (-3.12%)    TVIX (-4.25%)    VXX (-2.07%)    DFRG (2.06%)    CMG (-0.69%)    ACAD (2.45%)    MSFT (0.05%)    MCHP (-1.44%)    MAXR (-13.79%)    IRBT (0.03%)    IP (-0.24%)    INTC (0.09%)    GDX (0.64%)    FTNT (0.33%)    FE (-0.68%)    ECOR (-4.53%)    DNR (3.23%)    BIOC (9.74%)

 AVEO - AVEO Pharmaceuticals

$0.70 [0.01][0.77%]

Next Earnings

8/6/2019

AMC

Recommend
Trade Idea »



OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $AVEO

TRENDING ARTICLES



Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options

05/22/19
Investors in AVEO Pharmaceuticals Inc AVEO need to pay close attention to the stock based on moves in the options market lately That is because the Oct 18 2019 1 00 Call had some of the highest implied volatility of all equity options today What is Implied Volatility

AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark

05/11/19
AVEO Pharmaceuticals Inc AVEO incurred first quarter 2019 loss of 6 cents per share wider than the Zacks Consensus Estimate of a loss of 5 cents but narrower than the year ago loss of 8 cents AVEO s top line comprises collaboration and licensing revenues plus partnership royalties

AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark

05/10/19
AVEO Pharmaceuticals Inc AVEO incurred first quarter 2019 loss of 6 cents per share wider than the Zacks Consensus Estimate of a loss of 5 cents but narrower than the year ago loss of 8 cents AVEO s top line comprises collaboration and licensing revenues plus partnership royalties

AVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Tops Revenue Estimates

05/09/19
AVEO Pharmaceuticals AVEO came out with a quarterly loss of 0 06 per share versus the Zacks Consensus Estimate of a loss of 0 05 This compares to loss of 0 08 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings surprise

AVEO Pharmaceuticals (AVEO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

05/07/19
The market expects AVEO Pharmaceuticals AVEO to deliver a year over year increase in earnings on lower revenues when i t report s results for the quarter ended March 2019 This widely known consensus outlook is important in assessing the company s earnings picture but a powerful factor

AVEO Pharmaceuticals (AVEO) Dips More Than Broader Markets: What You Should Know

05/02/19
In the latest trading session AVEO Pharmaceuticals AVEO closed at 0 91 marking a 1 42 move from the previous day This move lagged the S amp P 500 s daily loss of 0 75 Meanwhile the Dow lost 0 61 and the Nasdaq a tech heavy index lost 0 57 Heading into today shares of the

AVEO Pharmaceuticals (AVEO) to Post Q1 Earnings: What's Up?

04/30/19
AVEO Pharmaceuticals Inc AVEO will report first quarter 2019 earnings results The company s performance over the last four quarters has been mixed so far with two earnings beat as well as a couple of misses The average negative surprise over the trailing four quarters is 24 41 In the las